BANK OF AMERICA CORP /DE/ - RXI PHARMACEUTICALS CORP NEW ownership

Back to all holdings Add to watchlist

RXI PHARMACEUTICALS CORP NEW's ticker is RXII and the CUSIP is 74979C808. A total of 14 filers reported holding RXI PHARMACEUTICALS CORP NEW in Q3 2018. The put-call ratio across all filers is - and the average weighting 0.0%.

Links
Filings
External links
Quarter-by-quarter ownership
BANK OF AMERICA CORP /DE/ ownership history of RXI PHARMACEUTICALS CORP NEW
ValueSharesWeighting
Q3 2018$1,000–548
+717.9%
0.00%–
Q2 2018$0–67
+3.1%
0.00%–
Q1 2018$0–65–0.00%–
 Download
Other shareholders

There were no reported owners of RXI PHARMACEUTICALS CORP NEW in Q3 2018.

NameSharesValueWeighting ↓
View complete list of RXI PHARMACEUTICALS CORP NEW shareholders